These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1034 related items for PubMed ID: 3335601

  • 1. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J, Hosoya T, Naito N, Yoshimura H, Kohno Y, Tarutani O, Kuma K, Sakane S, Takeda K, Mozai T.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [Abstract] [Full Text] [Related]

  • 2. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR.
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [Abstract] [Full Text] [Related]

  • 3. Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease.
    Takamatsu J, Takeda K, Katayama S, Sakane S, Morita S, Kuma K, Ohsawa N.
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1145-50. PubMed ID: 1400885
    [Abstract] [Full Text] [Related]

  • 4. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
    Yamada T, Koizumi Y, Sato A, Hashizume K, Aizawa T, Takasu N, Nagata H.
    J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
    [Abstract] [Full Text] [Related]

  • 5. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A, Yamada T, Aizawa T, Ichikawa K, Komiya I, Takasu N, Takemura Y.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [Abstract] [Full Text] [Related]

  • 6. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ, Ladenson PW.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [Abstract] [Full Text] [Related]

  • 7. Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism.
    Laurberg P.
    J Clin Endocrinol Metab; 1987 May; 64(5):969-74. PubMed ID: 3558731
    [Abstract] [Full Text] [Related]

  • 8. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
    Izumi M, Larsen PR.
    J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M, Koizumi Y, Aizawa T, Yamada T, Takahashi Y, Watanabe T, Kamoi K.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [Abstract] [Full Text] [Related]

  • 11. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
    Okamoto Y, Hamada N, Saito H, Ohno M, Noh J, Ito K, Morii H.
    J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
    [Abstract] [Full Text] [Related]

  • 12. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
    Nakazato N, Yoshida K, Mori K, Kiso Y, Sayama N, Tani JI, Nakagawa Y, Ito S.
    Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
    [Abstract] [Full Text] [Related]

  • 13. Short and long term effects of radioiodine treatment on the iodine content of the thyroid gland.
    Schlumberger M, Fragu P, Hill C, Parmentier C, Tubiana M.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):893-8. PubMed ID: 6548226
    [Abstract] [Full Text] [Related]

  • 14. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N, Yabu Y, Miki T, Morimoto S, Kumahara Y, Mori H, Iwatani Y, Nishi K, Nakatani K, Miyai K.
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [Abstract] [Full Text] [Related]

  • 15. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease.
    Takamatsu J, Sugawara M, Kuma K, Kobayashi A, Matsuzuka F, Mozai T, Hershman JM.
    Ann Intern Med; 1984 Mar; 100(3):372-5. PubMed ID: 6546484
    [Abstract] [Full Text] [Related]

  • 16. Sequential deiodination of thyroxine in human thyroid gland.
    Ishii H, Inada M, Tanaka K, Mashio Y, Naito K, Nishikawa M, Matsuzuka F, Kuma K, Imura H.
    J Clin Endocrinol Metab; 1982 Nov; 55(5):890-6. PubMed ID: 6896880
    [Abstract] [Full Text] [Related]

  • 17. Iodinating activity of thyroid tissue in toxic diffuse goiter.
    Nagataki S, Uchimura H, Ikeda H, Kuzuya N, Masuyama Y.
    J Clin Invest; 1977 Apr; 59(4):723-9. PubMed ID: 576614
    [Abstract] [Full Text] [Related]

  • 18. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
    Roti E, Minelli R, Gardini E, Bianconi L, Salvi M, Gavaruzzi G, Ugolotti G, Braverman LE.
    J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
    [Abstract] [Full Text] [Related]

  • 19. Acute effects of corticosteroids on thyroid activity in Graves' disease.
    Williams DE, Chopra IJ, Orgiazzi J, Solomon DH.
    J Clin Endocrinol Metab; 1975 Aug; 41(2):354-61. PubMed ID: 1174132
    [Abstract] [Full Text] [Related]

  • 20. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS, Sirbu AE, Betivoiu MA, Florea S, Barbu CG, Fica SV.
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.